Effects of infusion of adenosine triphosphate-magnesium chloride on cardiopulmonary and clinicopathologic variables, cytokine activity, and endothelin concentration in horses administered a low dose of endotoxin

American Journal of Veterinary Research

Volumn 65, Issue 2, 2004, Pages 225-237

  Tetens, Joanne ^a,b,c   Moore, M Rustin ^a,b   Hosgood, Giselle L ^a   Eades, Susan C ^a   Keowen, Michael L ^b   Horohov, David W ^b,d  

^a LOUISIANA STATE UNIVERSITY   (United States)

^b LOUISIANA STATE UNIVERSITY   (United States)

^c Equine Center   (United States)

^d UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE NUCLEOTIDE; ADENOSINE TRIPHOSPHATE; ADENOSINE TRIPHOSPHATE MAGNESIUM; CYTOKINE; ENDOTHELIN; ESCHERICHIA COLI ENDOTOXIN; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; SODIUM CHLORIDE; BICARBONATE; CARBON DIOXIDE; ENDOTOXIN; OXYGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATTENUATION; BLOOD CLOTTING DISORDER; CARDIOPULMONARY HEMODYNAMICS; CARDIOVASCULAR RESPONSE; CLINICAL FEATURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISEASE EXACERBATION; DOSE RESPONSE; ENDOTOXEMIA; FEMALE; JUGULAR VEIN; LEUKOCYTE ADHERENCE; LEUKOPENIA; MALE; NEUTROPENIA; NONHUMAN; PROTEIN BLOOD LEVEL; PULMONARY ARTERY; PULMONARY HYPERTENSION; RECORDING; RESPIRATORY FUNCTION; SHOCK; SYSTEMIC DISEASE; THROMBOCYTOPENIA; TREATMENT FAILURE; ANIMAL; ANIMAL DISEASE; BLOOD; BLOOD EXAMINATION; BODY TEMPERATURE; COMPARATIVE STUDY; DRUG EFFECT; HEMODYNAMICS; HORSE; INTRAVENOUS DRUG ADMINISTRATION; METABOLISM; PH; PHYSIOLOGY;

ANIMALIA; EQUIDAE; ESCHERICHIA COLI;

ADENOSINE TRIPHOSPHATE; ANIMALS; BICARBONATES; BODY TEMPERATURE; CARBON DIOXIDE; CYTOKINES; ENDOTHELINS; ENDOTOXINS; HEMATOLOGIC TESTS; HEMODYNAMIC PROCESSES; HORSES; HYDROGEN-ION CONCENTRATION; INFUSIONS, INTRAVENOUS; OXYGEN;

EID: 1542300781     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.2004.65.225     Document Type: Article

References (55)

1. Moore J. Recognition and treatment of endotoxemia. Vet Clin North Am Equine Pract 1988;4:105-113.
2. Morris D. Endotoxemia in horses: a review of cellular and humoral mediators involved in its pathogenesis. J Vet Intern Med 1991; 5:167-181.
3. McClure J. Endotoxic shock. Vet Clin North Am 1976;6: 193-202.
4. King J, Gerring E. Detection of endotoxin in cases of equine colic. Vet Rec 1988;123:269-271.
5. Shuster R, Traub-Dargatz J, Baxter G. Survey of diplomates of the American College of Veterinary Internal Medicine and the American College of Veterinary Surgeons regarding clinical aspects and treatment of endotoxemia in horses. J Am Vet Med Assoc 1997;210:87-92.
6. MacKay R. Endotoxemia. In. Robinson NE, ed. Current therapy in equine medicine 3. Philadelphia: WB Saunders Co, 1992;225-232.
7. Burrows GE. Hemodynamic alterations in the anesthetized pony produced by slow intravenous administration of Escherichia coli endotoxin. Am J Vet Res 1970;31:1975-1982.
8. MacKay RJ, Merritt AM, Zertuche JM, et al. Tumor necrosis factor activity in the circulation of horses given endotoxin. Am J Vet Res 1991;52:533-538.
9. Bueno AC, Seahorn TL, Cornick-Seahorn J, et al. Plasma and urine nitric oxide concentrations in horses given below a low dose of endotoxin. Am J Vet Res 1999;60:969-976.
10. Brigham K, Meyrick B. Endotoxin and lung injury. Am Rev Respir Dis 1986;133:913-927.
11. Myhre U, Pettersen JT, Risoe C, et al. Endothelin-1 and endotoxemia. J Cardiovasc Pharmacol 1993;22:S291-S294.
12. Yanagisawa M, Kurihara H, Kimura S, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988;332:411-415.
13. Morel R, Lacroix J, Hemsen A, et al. Increased plasma and pulmonary lymph levels of endothelin during endotoxin shock. Eur J Pharmacol 1989;167:427-428.
14. Ingle-Fehr JE, Baxter GM. Evaluation of digital and laminar blood flow in horses given a low dose of endotoxin. Am J Vet Res 1998; 59:192-196.
15. Chaudry IH. Cellular mechanisms in shock and ischemia and their correction. Am J Physiol 1983;245:R117-R134.
16. Sumpio BE, Chaudry IH, Baue AE. Adenosine triphosphate-magnesium chloride ameliorates reperfusion injury following ischemia as determined by phosphorus nuclear magnetic resonance. Arch Surg 1985;120:233-240.
17. 2. Surg Forum 1985;36:244-246.
18. 2 restores depressed endothelial cell function after hemorrhagic shock and resuscitation. Am J Physiol 1995;268:H1390-H1396.
19. 2 after trauma-hemorrhage and resuscitation restores the depressed cardiac performances. J Surg Res 1997;69:159-165.
20. 2 following hemorrhagic shock. Circ Shock 1983;11:141-148.
21. 2 administration normalizes macrophage cAMP and β-adrenergic receptors after hemorrhage and resuscitation. Am J Physiol 1994;267:G52-G58.
22. 2 following trauma-hemorrhage and resuscitation: downregulation of inflammatory cytokine (TNF, IL-6) release. J Surg Res 1992;52:364-371.
23. Tetens J, Bueno AC, Cornick-Seahorn JL, et al. Hemodynamic and metabolic alterations associated with intravenous infusion of a combination of adenosine triphosphate and magnesium chloride in conscious horses. Am J Vet Res 1999;60:1140-1147.
24. 2 in healthy anesthetized horses. Am J Vet Res 2001;62:1240-1249.
25. 2 and precautions for its use in the study and treatment of shock and ischemia. Am J Physiol 1982;242:R604-R605.
26. Guyton A. Overview of the circulation; medical physics of pressure, flow, and resistance. In: Guyton AC, Hall JE, eds. Textbook of medical physiology. 9th ed. Philadelphia: WB Saunders Co, 1996;161-169.
27. Nakai S, Mizuno M, Kaneta M, et al. A simple sensitive bioassay for detection of interleukin-1 using human melanoma A375 cell fine. Biochem Biophys Res Comm 1988;154:1189-1196.
28. Pluznik D, Frappier N, Nordan R. Interleukin-6 (interferon B2) and interferon alpha/B present in post-endotoxin serum induced differentiation of murine M1 myeloid leukemia cells. Exp Hematol 1989; 17:1063-1066.
29. MacKay RJ, Lester GD. Induction of the acute-phase cytokine, hepatocyte-stimulating factor/interleukin 6, in the circulation of horses treated with endotoxin. Am J Vet Res 1992;53:1285-1289.
30. Durando MM, MacKay RJ, Linda S, et al. Effects of polymyxin B and Salmonella typhimurium antiserum on horses given endotoxin intravenously. Am J Vet Res 1994;55:921-927.
31. Rhyne A, Stelle R. Tables for a treatments versus control multiple comparisons sign test. Technometrics 1965;7:293-306.
32. Longworth KE, Smith BE, Staub NC, et al. Use of detergent to prevent initial responses to endotoxin in horses. Am J Vet Res 1996; 57:1063-1066.
33. Clark ES, Gantley B, Moore JN. Effects of slow infusion of a low dosage of endotoxin on systemic haemodynamics in conscious horses. Equine Vet J 1991;23:18-21.
34. 2 in the evaluation and treatment of children with pulmonary hypertension secondary to congenital heart defects. Circulation 1994; 90:1287-1293.
35. Ali A, Goldberg RN, Suguihara C, et al. Effects of ATP-magnesium chloride on the cardiopulmonary manifestations of group B streptococcal sepsis in the piglet. Pediatr Res 1996;39:609-615.
36. Ralevic V, Burnstock G. Receptors for purines and pyrimidines. Pharmacol Rev 1998;50:413-492.
37. Shapiro M, Jellinek M, Pyrros D, et al. Clearance and maintenance of blood nucleotide levels with adenosine triphosphate-magnesium chloride injection. Circ Shock 1992;36:62-67.
38. Freyer DR, Boxer LA, Axtell RA, et al. Stimulation of human neutrophil adhesive properties by adenine nucleotides. J Immunol 1988;141:580-586.
39. Dawicki DD, McGowan-Jordan J, Bullard S, et al. Extracellular nucleotides stimulate leukocyte adherence to cultured pulmonary artery endothelial cells. Am J Physiol 1995;268:L666-L673.
40. Morris DD, Crowe N, Moore JN. Correlation of clinical and laboratory data with serum tumor necrosis factor activity in horses with experimentally induced endotoxemia. Am J Vet Res 1990;51:1935-1940.
41. Fredholm BB. Purities and neutrophil leukocytes. Gen Pharmacol 1997;28:345-350.
42. Burrows G. Hematologic alterations associated with acute E coli endotoxemia, in Proceedings. 1st Int Symp Equine Hematol 1975; 505-515.
43. Meyers KM, Holmsen H, Seachord CL. Comparative study of platelet dense granule constituents. Am J Physiol 1982;243:R454-R461.
44. Poole AW, Heath MF, Evans RJ. ADP induces desensitisation of equine platelet aggregation responses: studies using ADP beta S, a stable analogue of ADP. Res Vet Sci 1993;54:235-243.
45. Jarvis GE, Evans RJ. Endotoxin-induced platelet aggregation in heparinised equine whole blood in vitro. Res Vet Sci 1994;57:317-324.
46. Jarvis GE, Evans RJ, Heath MF. The role of ADP in endotoxin-induced equine platelet activation. Eur J Pharmacol 1996;315: 203-212.
47. Vemulapalli S, Chiu PJ, Rivelli M, et al. Modulation of circulating endothelin levels in hypertension and endotoxemia in rats. J Cardiovasc Pharmacol 1991;18:895-903.
48. Myhre U, Petersen JT, Pisoe C, et al. Endothelin-1 and endotoxemia. J Cardiovasc Pharmacol 1993;22:S291-S294.
49. Kaszaki J, Wolfard A, Boros M, et al. Effects of antiendothelin treatment on the early hemodynamic changes in hyperdynamic endotoxemia. Acta Chir Hung 1997;36:152-153.
50. Wagner OF, Christ G, Wojta J, et al. Polar secretion of endothelin-1 by cultured endothelial cells. J Biol Chem 1992;267: 16066-16068.
51. Templeton CB, Bottoms GD, Fessler JF, et al. Endotoxin-induced hemodynamic and prostaglandin changes in ponies: effects of flunixin meglumine, dexamethasone, and prednisolone. Circ Shock 1987;23:231-240.
52. Ward DS, Fessler JF, Bottoms GD, et al. Equine endotoxemia: cardiovascular, eicosanoid, hematologic, blood chemical, and plasma enzyme alterations. Am J Vet Res 1987;48:1150-1156.
53. Snapper JR, Thabes JS, Lefferts PL, et al. Role of endothelin in endotoxin induced sustained pulmonary hypertension in sheep. Am J Respir Crit Care Med 1997;157:81-88.
54. Haglund U, Lundgren O. Intestinal ischemia and shock factors. Fed Proc 1987;37:2729-2733.
55. Ramaswamy CM, Eades SC, Venugopal CS, et al. Plasma concentrations of endothelin-like immunoreactivity in healthy horses and horses with naturally acquired gastrointestinal tract disorders. Am J Vet Res 2002;63:454-458.